Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2018 Dec 14;7(4):1277–1284. doi: 10.1016/j.jaip.2018.12.004

TABLE I.

Comparison of immunologic parameters between CVID and IgG deficient patient cohorts

CVID
(total n = 128)
IgG deficiency
(total n = 124)
p value
Immunoglobulin level means (in mg/dl)
IgG (nl 767-1,590 mg/dL) 255 (226 - 285) (n = 120) 556 (527 - 584) (n =124) <0.0001
IgA (nl 61-356 mg/dL) 19.8 (15.2 - 24.5) (n = 126) 102 (90.0 - 113) (n = 124) <0.0001
IgM (nl 37-286 mg/dL) 45.8 (31.6 - 60.0) (n = 126) 99.5 (87.1 - 112) (n = 124) <0.0001
Percentage of patients with protective protein/conjugate serologic titers
Haemophilus influenzae B 46.2 (30.3 - 62.1) (n = 39) 66.3 (55.9 - 76.7) (n = 80) 0.036
Measles 57.8 (43.2 - 72.4) (n = 45) 88.5 (81.8 - 95.3) (n = 87) <0.0001
Mumps 54.5 (39.6 - 69.4) (n = 44) 80.9 (72.7 - 89.1) (n = 89) 0.001
Rubella 84.4 (73.7 - 95.1) (n = 45) 93.2 (87.9 - 98.5) (n = 88) 0.11
Tetanus 63.3 (49.7 - 76.9) (n = 49) 96.7 (93.1 - 100) (n = 88) <0.0001
Diphtheriaw 71.1 (56.5 - 85.7) (n = 38) 93.2 (87.3 - 99.0) (n = 73) 0.001
Varicella 58.3 (42 - 74.6) (n = 36) 93.4 (87.8 - 99.0) (n = 76) <0.0001
Sum of protective serologies to pneumococcal serotypes (means)
3.08 (2.12 - 4.04) (n = 60) 6.51 (5.78 -7.24) (n = 121) <0.0001
T cell populations (absolute count means in cells/mm3)
CD3+ (nl 900- 2100) 1209 (1070 - 1350) (n = 94) 1344 (1150 - 1530) (n = 65) 0.25
CD3+CD4+ (nl 500-1500) 680 (606 - 753) (n = 92) 957 (812 - 1100) (n = 65) 0.0004
CD3+CD8+ (nl 150-1000) 489 (403 - 574) (n = 92) 362 (304 - 421) (n = 65) 0.03
B cells populations (means)
CD19+ (absolute, cells/mm3) nl = 74.4-441.1 205 (158 - 251) (n = 94) 258 (202 - 313) (n = 67) 0.15
CD19+CD27+ (% of B cells) nl = 33.6-44.2 24.8 (20.9 - 28.8) (n = 111) 41.0 (33.6 - 48.5) (n = 33) 0.0002
CD19+CD27+ (absolute cells/mm3) 31.2 (22.4 - 40.0) (n = 85) 97.5 (54.2 - 141) (n = 22) <0.0001
CD19+CD27+IgD- (% of B cells) nl = 20.8-24.3% 2.85 (1.72 - 3.98) (n = 111) 10.9 (8.28 - 13.4) (n = 33) <0.0001
CD19+CD27+IgD- (absolute, cells/mm3) 3.65 (1.53 - 5.77) (n = 85) 29.6 (16.5 - 42.7) (n = 22) <0.0001